Astec LifeSciences posts Q3 FY24 consolidated loss at Rs. 24.33 Cr
News

Astec LifeSciences posts Q3 FY24 consolidated loss at Rs. 24.33 Cr

Astec LifeSciences has reported total income of Rs. 51.70 crores during the period ended December 31, 2023

  • By IPP Bureau | January 26, 2024

Astec LifeSciences Limited has reported consolidated financial results for the period ended December 31, 2023.

Astec LifeSciences has posted net loss of Rs. 24.33 crores for the period ended December 31, 2023 as against net loss of Rs. 13.42 crores for the period ended September 30, 2023. It posted net profit of Rs.0.83 crores for the period ended December 31, 2022.

Astec LifeSciences has reported total income of Rs. 51.70 crores during the period ended December 31, 2023 as compared to Rs. 111.76 crores during the period ended September 30, 2023. It reported total income of Rs.120.96 crores during the period ended December 31, 2022.

For the 9 months period ended December 31, 2023, Astec LifeSciences has reported total income of Rs.308.02 crores as compared to Rs.511.67 crores during the 9 months period ended December 31, 2022.

The company has posted net loss of Rs.45.95 crores for the 9 months period ended December 31, 2023 as against net profit of Rs.30.54 crores for the 9 months period ended December 31, 2022.

Upcoming E-conference

Other Related stories

Startup

Digitization